EC Number | Application | Comment | Organism |
---|---|---|---|
3.3.2.6 | pharmacology | inhibition of LTA4H is a potential therapeutic strategy that can modulate key aspects of asthma | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.3.2.6 | JNJ 26993135 | a selective LTA4H inhibitor, leads to reduction of TH2 cytokines and mucin levels, and blocks mast cell production of LTB4 and suppresses airway hyperresponsiveness | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.3.2.6 | Mus musculus | - |
Balb/c mice | - |
3.3.2.6 | Mus musculus BALB/c | - |
Balb/c mice | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.3.2.6 | lung | - |
Mus musculus | - |
3.3.2.6 | mast cell | bone marrow-derived | Mus musculus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.3.2.6 | leukotriene A4 hydrolase | - |
Mus musculus |
3.3.2.6 | LTA4H | - |
Mus musculus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.3.2.6 | malfunction | enzyme inhibition blocks lung inflammation, antigen uptake by lung dendritic cells and subsequent trafficking of dendritic cells to draining lymph nodes and the lung are decreased upon enzyme inhibition | Mus musculus |
3.3.2.6 | physiological function | leukotriene A4 hydrolase is involved in recruitment of both CD4+ and CD8+ T cells to inflammation sites, as well as trafficking of dendritic cells to draining lymph nodes | Mus musculus |